Salvador
Martín Algarra
Consultor Médico
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (7)
2021
-
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 6, pp. 586-598
2019
-
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma
Oncologist, Vol. 24, Núm. 10, pp. 1375-1383
2017
-
Highlights of the season 2016-2017 by the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
-
Infomelanoma 2020: An online digital application designed to assist health professionals for melanoma treatment
Annals of Translational Medicine, Vol. 5, Núm. 19, pp. 1-9
-
Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
-
Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)
Annals of Translational Medicine, Vol. 5, Núm. 19
-
Special issue on II translational meeting from the Spanish melanoma group
Annals of Translational Medicine, Vol. 5, Núm. 19, pp. 1